RAS mutations, including those in NRAS and KRAS, are commonly observed in pediatric AML as well as in ALL, occurring in 6% of AMKL with CBFA2T3::GLIS2 (8,9). The gene discussed is KRAS; the disease is acute myeloid leukemia.